https://www.pharmaradar360.com/article/e4f854e3d4f51dc3Pharma Surgeen2026-05-16T10:00:39.000ZMakary resigns; Biogen reports Alzheimer’s data; and morehttps://www.pharmaradar360.com/article/77cad67ae828b655Pharma Surgeen2026-05-16T00:02:51.000ZHantavirus: una amenaza silenciosahttps://www.pharmaradar360.com/article/eab45960c9862402Pharma Surgeen2026-05-16T00:00:00.000ZrAAV8 encapsidated HMR-001/z enables high efficiency hepatic transduction and restores hemostasis in hemophilic micehttps://www.pharmaradar360.com/article/d61996e45d32bbcaPharma Surgeen2026-05-16T00:00:00.000Znatco records %e2%82%b9705 4 crore consolidated revenue and %e2%82%b9151 3 crore of profit after tax for q3fy26https://www.pharmaradar360.com/article/cf3b949986c87addPharma Surgeen2026-05-16T00:00:00.000Znatco records %e2%82%b91463 crore consolidated revenue and %e2%82%b9517 9 crore of profit after tax for q2fy26https://www.pharmaradar360.com/article/61a15a4d033e288bPharma Surgeen2026-05-16T00:00:00.000Znatco receives tentative approval for erdafitinib tablets generic of balversa from the united states food and drug administration u s fdahttps://www.pharmaradar360.com/article/5f5316d842af9757Pharma Surgeen2026-05-16T00:00:00.000Znatco receives approval from central drug standard control organisation cdsco for semaglutide in indiahttps://www.pharmaradar360.com/article/5b58248df55623abPharma Surgeen2026-05-16T00:00:00.000Znatco pharma limited api unit in chennai receives establishment inspection report eir from u s fdahttps://www.pharmaradar360.com/article/a2bc69aa41da3439Pharma Surgeen2026-05-16T00:00:00.000Znatco pharma launches semaglutide generic injection multi dose vials in india at the most affordable price starting from mrp inr 1290https://www.pharmaradar360.com/article/dca0c78e2e1c375ePharma Surgeen2026-05-16T00:00:00.000Znatco announces launch of pomalidomide capsules generic of pomalyst in the u s markethttps://www.pharmaradar360.com/article/7cc84588c7fefd0dPharma Surgeen2026-05-16T00:00:00.000Znatco announces launch of its everolimus tablets 1 mg generic of zortresshttps://www.pharmaradar360.com/article/914dfaaffe288227Pharma Surgeen2026-05-16T00:00:00.000Zlegal update regarding risdiplamhttps://www.pharmaradar360.com/article/f9f15141d6ce66d4Pharma Surgeen2026-05-16T00:00:00.000Zintimation under regulation 30 of sebi listing obligations and disclosure requirements regulations 2015 2https://www.pharmaradar360.com/article/ca5a5783405871f5Pharma Surgeen2026-05-16T00:00:00.000Zdisclosure under regulation 30 of the sebi listing obligations and disclosure requirements regulations 2015https://www.pharmaradar360.com/article/62109d04b5968994Pharma Surgeen2026-05-16T00:00:00.000Zadcock ingram completes delisting from jse natco pharma acquires 35 75 stakehttps://www.pharmaradar360.com/article/d3b395d9bc0e7f72Pharma Surgeen2026-05-16T00:00:00.000Z6203https://www.pharmaradar360.com/article/df9bea78d93b56bbPharma Surgeen2026-05-16T00:00:00.000ZHome pagehttps://www.pharmaradar360.com/article/b3bb9ae360a2e951Pharma Surgeen2026-05-15T21:45:51.000ZTwo additional MV Hondius passengers arrive at National Quarantine Unithttps://www.pharmaradar360.com/article/9c759b79009e90eePharma Surgeen2026-05-15T21:41:07.000ZCU Anschutz Researchers Discover New Clues to Delaying Type 1 Diabeteshttps://www.pharmaradar360.com/article/7e249b38ad7d429fPharma Surgeen2026-05-15T21:13:18.000ZUC impulsa una Vinculación con el Medio más articulada y conectada con desafíos públicoshttps://www.pharmaradar360.com/article/6ffcd0d12cc93367Pharma Surgeen2026-05-15T21:13:08.000ZTauber recibió a representantes de la Fundación Alemana Friedrich Ebert y de la Red FICEhttps://www.pharmaradar360.com/article/744b1a5fe33ff1f6Pharma Surgeen2026-05-15T21:12:58.000ZLa UNLP impulsa políticas de género y derechos humanos en el transportehttps://www.pharmaradar360.com/article/a0a9352b121c0f0cPharma Surgeen2026-05-15T21:12:25.000ZConvenio con el Ministerio de Justicia para fortalecer las prácticas de Psicologíahttps://www.pharmaradar360.com/article/0b8766ba21bfb192Pharma Surgeen2026-05-15T20:49:19.000Z12 Fruits and Vegetables That Thrive in Shady Gardenshttps://www.pharmaradar360.com/article/e14a3805cba7fe05Pharma Surgeen2026-05-15T20:48:57.000ZUS teens getting less sleep than ever, new report findshttps://www.pharmaradar360.com/article/d6c54d511bdb1eaaPharma Surgeen2026-05-15T20:48:29.000ZBefore cutting down trees, Raptor Center asks Minnesotans to check for ‘hoos’ insidehttps://www.pharmaradar360.com/article/298e4ae67e9feb3dPharma Surgeen2026-05-15T20:27:01.000ZCDER chief Høeg fired from FDA as other top roles turn overhttps://www.pharmaradar360.com/article/78b1c0afb8a9d375Pharma Surgeen2026-05-15T19:44:28.000ZFDA Rebuilding After DOGE Cuts: Former Regulators Speak Outhttps://www.pharmaradar360.com/article/c0bfefa11cbbadfdPharma Surgeen2026-05-15T19:39:25.000ZRAGE Implicated in Worsening Breast Cancer Mortality with Agehttps://www.pharmaradar360.com/article/36fbed45ea3c8b10Pharma Surgeen2026-05-15T19:29:44.000ZMultiomic ALS Study Links Peripheral Immune Infiltration to CNS Inflammationhttps://www.pharmaradar360.com/article/2e7cd4b3183b6603Pharma Surgeen2026-05-15T19:15:00.000ZBlood pressure stations make health simple at YMCA of Central Texashttps://www.pharmaradar360.com/article/9a5bc699c3376104Pharma Surgeen2026-05-15T19:11:03.000ZPOLÍTICA DE PRIVACIDADEhttps://www.pharmaradar360.com/article/23512d5c50d1b250Pharma Surgeen2026-05-15T18:33:00.000ZTwo Chicago changemakers triumph in competition to end cardiovascular diseasehttps://www.pharmaradar360.com/article/ba5bb2f699e97882Pharma Surgeen2026-05-15T18:26:42.000ZCurrent and Expired PEPFAR Reporting Requirementshttps://www.pharmaradar360.com/article/63cceb6f2b8f7fb6Pharma Surgeen2026-05-15T18:24:42.000ZClosing the care gaphttps://www.pharmaradar360.com/article/d2bea7d690cb6470Pharma Surgeen2026-05-15T18:23:39.000ZWhere nursing meets its deepest questionshttps://www.pharmaradar360.com/article/c12b2086e09e6702Pharma Surgeen2026-05-15T18:22:05.000ZA new approach to dementia carehttps://www.pharmaradar360.com/article/d367dd496650193bPharma Surgeen2026-05-15T18:15:33.000ZPharmaceutical Executive Daily: FDA Approves AstraZeneca's Fasenrahttps://www.pharmaradar360.com/article/83125d7ed6836c52Pharma Surgeen2026-05-15T17:56:32.000ZBiopharma M&A maintains strength even as large deals wanehttps://www.pharmaradar360.com/article/bd2eda2e6a9c8dc9Pharma Surgeen2026-05-15T17:52:37.000ZAir Force, Marine veterans earn data science master’s degreeshttps://www.pharmaradar360.com/article/a6fb309dd2af4e28Pharma Surgeen2026-05-15T17:44:27.000ZDiversity in Dermatology Clinical Trialshttps://www.pharmaradar360.com/article/f521a1c0548f6f74Pharma Surgeen2026-05-15T17:36:31.000ZDesigning Pivotal ADC Trials That Actually Enrollhttps://www.pharmaradar360.com/article/817308b6e2b34867Pharma Surgeen2026-05-15T17:31:40.000ZAmgen expands crackdown on what it says is misuse of 340B programhttps://www.pharmaradar360.com/article/12b9b000686c6cfdPharma Surgeen2026-05-15T17:20:54.000ZAvanza la agenda conjunta: Tauber se reunió con el ministro de Gobierno Carlos Biancohttps://www.pharmaradar360.com/article/946d65cd2085316aPharma Surgeen2026-05-15T17:20:16.000ZTauber y Alak avanzan en un plan para fortalecer la formación en oficioshttps://www.pharmaradar360.com/article/373e7626cba7e6f3Pharma Surgeen2026-05-15T16:59:29.000ZASGCT Q1 Landscape Report Paints Positive Picture for Gene and RNA Therapyhttps://www.pharmaradar360.com/article/8585d0ea3afc1575Pharma Surgeen2026-05-15T16:58:37.000ZMeet Cooper: NCAA Athlete and Life with Type 1 Diabeteshttps://www.pharmaradar360.com/article/49f980e54a6cd363Pharma Surgeen2026-05-15T16:49:24.000ZLa UNLP se suma a la Noche de las Ideas para difundir la cultura francesahttps://www.pharmaradar360.com/article/362cb550e27e318ePharma Surgeen2026-05-15T16:49:08.000ZTwo honored with inaugural Staff Advisory Council awardshttps://www.pharmaradar360.com/article/c32f716546c35731Pharma Surgeen2026-05-15T16:41:30.000ZMMI’s Autism Diagnostic Clinic: A new standard for accesshttps://www.pharmaradar360.com/article/3afce944443b6324Pharma Surgeen2026-05-15T16:35:32.000ZOff-the-Shelf Anti-CD19 CAR T-cell Therapy With Reduced or No Conditioning Chemotherapy Demonstrates Efficacy and Tolerability in Systemic Lupus Erythematosus: Meaningful Activity Supports Planned Adolescent Enrollmenthttps://www.pharmaradar360.com/article/3afcbc86398c91fbPharma Surgeen2026-05-15T16:34:12.000ZFT839: A Multi-Antigen Targeting Off-the-Shelf Dual-CAR T Cell for the Treatment of Pathogenic B and T Cells in Autoimmune Diseaseshttps://www.pharmaradar360.com/article/5efa8c757cd2266ePharma Surgeen2026-05-15T16:31:53.000ZSafety and Efficacy of an Off-the-Shelf Anti-CD19 CAR T-Cell Therapy With Reduced Conditioning in SLE: A Phase 1 Studyhttps://www.pharmaradar360.com/article/de71702ac6d16ec5Pharma Surgeen2026-05-15T16:30:44.000ZPrimeros diplomados en Inteligencia Artificial Generativahttps://www.pharmaradar360.com/article/8e17770df081d3f8Pharma Surgeen2026-05-15T16:30:29.000ZSe reanudan las clases recreativas y abiertas de la UNLPhttps://www.pharmaradar360.com/article/b28da1a940589618Pharma Surgeen2026-05-15T16:30:18.000ZFT819 Drives B cell Compartment Remodeling of Patients with Systemic Lupus Erythematosus Without Conditioning Chemotherapyhttps://www.pharmaradar360.com/article/641973dd635b6fbfPharma Surgeen2026-05-15T16:28:45.000ZCAR T cells Targeting pan-Tumor Antigens MICA/B can be Uniquely Combined with SOC Treatments without Conditioning Chemotherapy for Broad and Effective Therapeutic Application in Cancerhttps://www.pharmaradar360.com/article/2eef1681337ed6b6Pharma Surgeen2026-05-15T16:26:09.000ZMarley Brown recognized as outstanding provider by DHHShttps://www.pharmaradar360.com/article/7bc28061ecff6931Pharma Surgeen2026-05-15T16:16:00.000ZUsing Digital Technologies to Enhance Patient Experience and Better Manage Supply Chainhttps://www.pharmaradar360.com/article/b2ecd135e8682533Pharma Surgeen2026-05-15T16:14:28.000ZRecipients of the 2026 ECTRIMS Fellowships Announcedhttps://www.pharmaradar360.com/article/e883bac3fc3b5fb5Pharma Surgeen2026-05-15T16:12:00.000ZEnsuring Sustainability Throughout Drug and Device Developmenthttps://www.pharmaradar360.com/article/b4f5982c654425b8Pharma Surgeen2026-05-15T16:07:00.000ZECO 2026: indirect comparison favours Wegovy pill over Foundayohttps://www.pharmaradar360.com/article/9cee518f57632db1Pharma Surgeen2026-05-15T16:02:00.000ZUtilizing AI to Facilitate Combination Product Developmenthttps://www.pharmaradar360.com/article/f90c0ffa99a252b0Pharma Surgeen2026-05-15T16:00:00.000ZTexas Children's Hospital agrees to launch nation's first 'detransition clinic' to settle state, DOJ investigationhttps://www.pharmaradar360.com/article/4dd0aa8f5c00264bPharma Surgeen2026-05-15T15:55:44.000ZREGENXBIO to push for accelerated approval of DMD gene therapyhttps://www.pharmaradar360.com/article/95d6d1cc12ba50e2Pharma Surgeen2026-05-15T15:53:38.000ZLa Noche de las Ideas llega a la UNLP con cine francés y actividades abiertashttps://www.pharmaradar360.com/article/3f5a69d0593bda85Pharma Surgeen2026-05-15T15:53:00.000ZAchieving Effective Manufacturing Scaleup for Clinical and Commercial Successhttps://www.pharmaradar360.com/article/2d490512273bd092Pharma Surgeen2026-05-15T15:47:53.000Z12 de mayo 2026 – “Economía y Derechos Humanos”, la Catedra UNESCO de la UNLP propone declarar el tema de interés provincial por la Honorable Cámara de la Provincia de Buenos Aireshttps://www.pharmaradar360.com/article/6024f4d4be3dc0d8Pharma Surgeen2026-05-15T15:39:54.000ZUniversidades Nacionales se unen para pedir al Gobierno que cumpla la Ley de Financiamiento Universitariohttps://www.pharmaradar360.com/article/cc1254ee975b7debPharma Surgeen2026-05-15T15:38:00.000ZAdvances and Opportunities in Dual Chamber Injectableshttps://www.pharmaradar360.com/article/335589ffd435f493Pharma Surgeen2026-05-15T15:32:42.000ZBreakthrough Oxford study moves newborn screening for SMA towards nationwide rollouthttps://www.pharmaradar360.com/article/a4fd882652ac9773Pharma Surgeen2026-05-15T15:30:00.000ZCandel reports prostate cancer drug's long-term data ahead of FDA filinghttps://www.pharmaradar360.com/article/ca76bac5a4044fa3Pharma Surgeen2026-05-15T15:29:41.000ZCMS’ New Approach to Federal Medicaid Spending in Cases of Potential Fraudhttps://www.pharmaradar360.com/article/bafbc6143be2a674Pharma Surgeen2026-05-15T15:29:10.000ZNonprofits join forces to debut marketplace for shelved CGTshttps://www.pharmaradar360.com/article/bfa81cf85d10acedPharma Surgeen2026-05-15T15:28:44.000ZNonprofits join forces to debut marketplace for shelved CGTshttps://www.pharmaradar360.com/article/58603e3d9dd9bcafPharma Surgeen2026-05-15T15:21:51.000ZPost-Hoc Live: Makary's out at FDA and what comes nexthttps://www.pharmaradar360.com/article/ce644f9341c5cbd9Pharma Surgeen2026-05-15T15:14:03.000ZWhat the 2026 World Cup means for measles risk in Vancouverhttps://www.pharmaradar360.com/article/59d37ea014692c59Pharma Surgeen2026-05-15T15:08:38.000ZTrial Trends & Table Talk Event at OCT East Coast 2026https://www.pharmaradar360.com/article/21f28201ff50519bPharma Surgeen2026-05-15T15:06:00.000ZWhat a Strategic Partnership Looks Like in Practice: Inside the Takeda–Basil Collaboration That Delivered Tenfold Enrollmenthttps://www.pharmaradar360.com/article/7fc79f77215704e5Pharma Surgeen2026-05-15T15:05:00.000ZRoche's ctDNA-guided approach in post-surgical bladder cancer pays off with Tecentriq nodhttps://www.pharmaradar360.com/article/d185ff314dd111e8Pharma Surgeen2026-05-15T15:00:00.000ZJohn Oyler: Rewiring Operations in Oncologyhttps://www.pharmaradar360.com/article/0c9ecd134e704a7aPharma Surgeen2026-05-15T14:59:00.000ZEli Lilly on Site Enablement: Co-Designing Solutions with Siteshttps://www.pharmaradar360.com/article/8940dcf6b93db5a8Pharma Surgeen2026-05-15T14:59:00.000ZBen Goldsborough MP visits to learn about pioneering Vitamin D tomatoes studyhttps://www.pharmaradar360.com/article/5ad55e48da712e7ePharma Surgeen2026-05-15T14:53:20.000ZSlate on May 14https://www.pharmaradar360.com/article/aefc254b0d477196Pharma Surgeen2026-05-15T14:37:00.000ZBuilding Trust-Driven Partnerships: AstraZeneca’s Concierge Approach to Accelerating Site Activation and Enrollmenthttps://www.pharmaradar360.com/article/1f310f8ec84fb019Pharma Surgeen2026-05-15T14:36:10.000ZSK pharmteco CEO Interviewed at DCAT Week 2026 by Pharmaceutical Technologyhttps://www.pharmaradar360.com/article/c7317225bc0e21f9Pharma Surgeen2026-05-15T14:27:00.000ZDocs remain skeptical of insurers' pledge to ease prior auth: AMA surveyhttps://www.pharmaradar360.com/article/9d97490c7696d233Pharma Surgeen2026-05-15T14:22:19.000ZAardvark's next move after clinical hold; Alumis' verdict on Acelyrin assethttps://www.pharmaradar360.com/article/0b76d70e3d830663Pharma Surgeen2026-05-15T14:17:02.000ZNuevas incorporaciones al Código Alimentario Argentinohttps://www.pharmaradar360.com/article/764da27ebabfc02cPharma Surgeen2026-05-15T14:12:49.000ZScaling Universal Health Coverage: lessons from Indonesia's health insurancehttps://www.pharmaradar360.com/article/510f62dc2aae3be2Pharma Surgeen2026-05-15T14:07:35.000ZInformation about the criminal offence committed by a former employee of the University of Freiburghttps://www.pharmaradar360.com/article/b9a84c53451fdf3dPharma Surgeen2026-05-15T14:07:00.000Z#VOLONTARIATO. Più allegria in corsia…Un pomeriggio con i supereroi!https://www.pharmaradar360.com/article/80936cd10f429a09Pharma Surgeen2026-05-15T14:03:49.000ZActualización del sistema de identificación digital en envases de especialidades medicinaleshttps://www.pharmaradar360.com/article/096ea4111324df50Pharma Surgeen2026-05-15T14:01:29.000ZMollyann Brodie Receives AAPOR Award for Exceptionally Distinguished Achievementhttps://www.pharmaradar360.com/article/62a4c942111e7d87Pharma Surgeen2026-05-15T13:56:29.000ZFDA Places Full Clinical Hold on Aardvark Therapeutics’ ARD-101https://www.pharmaradar360.com/article/7b45cc533984c457Pharma Surgeen2026-05-15T13:55:36.000ZAAPS 2026 PHarmSCi 360https://www.pharmaradar360.com/article/67040a4e524ff289Pharma Surgeen2026-05-15T13:54:00.000ZBridging Access Gaps: Sponsor-Led Enablement of Research-Naïve Sites to Expand Patient Reachhttps://www.pharmaradar360.com/article/293c119fea8d24d8Pharma Surgeen2026-05-15T13:44:36.000ZOCT Southern California 2026https://www.pharmaradar360.com/article/62386e35b79a7866Pharma Surgeen2026-05-15T13:43:48.000ZA new tariff for fees has come into effecthttps://www.pharmaradar360.com/article/99d148cddad1f806Pharma Surgeen2026-05-15T13:41:21.000ZFederal Vaccine Injury Compensation Programs: Overview and Current Issueshttps://www.pharmaradar360.com/article/99ac48febfe46ea6Pharma Surgeen2026-05-15T13:33:36.000ZACCP 2026https://www.pharmaradar360.com/article/cc70b1ad2e743e2ePharma Surgeen2026-05-15T13:24:42.000ZContract Pharma 2026https://www.pharmaradar360.com/article/7a4300d424c6692bPharma Surgeen2026-05-15T13:19:00.000ZRolling Stone: Next-gen cannabinoids - the innovative race to manufacture compoundshttps://www.pharmaradar360.com/article/bec2beb764236cc6Pharma Surgeen2026-05-15T13:18:41.000ZWarnstreik am 19. Mai am Universitätsklinikum Heidelberg: Akutversorgung der Patienten ist gewährleistethttps://www.pharmaradar360.com/article/03b4f278bd9c8f59Pharma Surgeen2026-05-15T13:18:20.000ZASGCT 2026: Beverly Davidson Offers Vehicle and Route for Huntington’s Disease Gene Therapyhttps://www.pharmaradar360.com/article/10fef09af6f0a3c8Pharma Surgeen2026-05-15T13:17:54.000ZFDA Approves Fasenra for Hypereosinophilic Syndromehttps://www.pharmaradar360.com/article/465c6c0286a5f7b4Pharma Surgeen2026-05-15T13:15:32.000ZDDF America 2026https://www.pharmaradar360.com/article/a105e8d36ab7db89Pharma Surgeen2026-05-15T13:12:00.000ZAfter Makary departure, CDER chief Tracy Beth Høeg likely headed out at FDA: reporthttps://www.pharmaradar360.com/article/d73d778373e5f76dPharma Surgeen2026-05-15T13:12:00.000ZUPDATED: After Makary departure, CDER chief Tracy Beth Høeg headed out at FDAhttps://www.pharmaradar360.com/article/9b9a28d4fef3868bPharma Surgeen2026-05-15T13:08:42.000ZWhy labs are the missing link in patient identificationhttps://www.pharmaradar360.com/article/7c75b2ad5770ee20Pharma Surgeen2026-05-15T13:03:41.000ZASGCT 2026: AI-Optimized Cas12l Gene Editor Offers Compact Cas9 Alternativehttps://www.pharmaradar360.com/article/c47c820d3d412586Pharma Surgeen2026-05-15T13:02:45.000ZPreviously Unrecognized Manuscript from the Bibliotheca Palatina Rediscoveredhttps://www.pharmaradar360.com/article/0a92679f3938690aPharma Surgeen2026-05-15T12:59:44.000ZASGCT 2026: Rare Instance of AAV Integration into Human Genome Linked to Brain Tumorhttps://www.pharmaradar360.com/article/495877036e45df45Pharma Surgeen2026-05-15T12:58:42.000ZBecas internacionales de la Subsecretaría de Relaciones Internacionales e Interjurisdiccionales PBAhttps://www.pharmaradar360.com/article/705d49c3c10ad516Pharma Surgeen2026-05-15T12:46:11.000ZThe Relationship Between the Capital Markets and Biotech?https://www.pharmaradar360.com/article/6872715774eef0c0Pharma Surgeen2026-05-15T12:43:17.000ZM&A isn’t just for big pharma. Mid-size companies are stepping up deal huntshttps://www.pharmaradar360.com/article/951911af2420a700Pharma Surgeen2026-05-15T12:36:00.000ZOp-ed: Making America healthy again requires more than a committeehttps://www.pharmaradar360.com/article/47cb80899a6906cePharma Surgeen2026-05-15T12:30:26.000ZCon nuevas obras de puesta en valor, el histórico Museo recupera toda su luzhttps://www.pharmaradar360.com/article/98eba546e347ca00Pharma Surgeen2026-05-15T12:30:08.000ZDiaverum launches AI-powered kidney disease education toolhttps://www.pharmaradar360.com/article/5a4d5d34a445e6ddPharma Surgeen2026-05-15T12:30:00.000ZECO 2026: tirzepatide shows potential for T1D treatmenthttps://www.pharmaradar360.com/article/18ffbfea2def5ce0Pharma Surgeen2026-05-15T12:25:00.000ZRare seals spotted snoozing in an underwater ‘bubble cave’https://www.pharmaradar360.com/article/68066d132da68970Pharma Surgeen2026-05-15T12:25:00.000ZMurder, monsters, occupational hazards: Why movie geologists die so oftenhttps://www.pharmaradar360.com/article/1a5b9e16452c0ae7Pharma Surgeen2026-05-15T12:22:13.000ZLEA-WH Fellowship Immersion Week Kicks Offhttps://www.pharmaradar360.com/article/6ab525ddd00817cdPharma Surgeen2026-05-15T12:22:08.000ZKEMRI Researcher Leads Charge to Transform Mental Healthcare in Kenyahttps://www.pharmaradar360.com/article/4a60311c52251299Pharma Surgeen2026-05-15T12:18:42.000ZIs cannabis safe after 65? Stanford experts reveal 5 risks older adults should knowhttps://www.pharmaradar360.com/article/837d1218c61710bbPharma Surgeen2026-05-15T12:13:20.000ZANMAT incorpora modificaciones del MERCOSUR sobre sustancias en cosméticoshttps://www.pharmaradar360.com/article/a2fe015b76049d17Pharma Surgeen2026-05-15T12:12:54.000ZBOS Manchester 2026https://www.pharmaradar360.com/article/4e513ab7db637780Pharma Surgeen2026-05-15T12:05:21.000Z4th Annual COG Europe 2026https://www.pharmaradar360.com/article/ada851c4ed90c77bPharma Surgeen2026-05-15T12:00:00.000ZCAR-T therapy for stiff person syndrome nears approvalhttps://www.pharmaradar360.com/article/d5b1ea10032800f6Pharma Surgeen2026-05-15T12:00:00.000ZRestructuring hospitals to help the elderlyhttps://www.pharmaradar360.com/article/5b76afbbfc61995bPharma Surgeen2026-05-15T11:53:09.000ZSUPPLY AND DELIVERY OF VARIOUS MEDICAL EQUIPMENT TENDER NO. AMREF/15/05/2026/008https://www.pharmaradar360.com/article/4c2b3ec72089c531Pharma Surgeen2026-05-15T11:47:46.000ZAspen Athletics Club shines at the Two Oceans Marathonhttps://www.pharmaradar360.com/article/7661d72b1488b4f1Pharma Surgeen2026-05-15T11:44:45.000ZScientists discover vitamin B2 may help cancer cells survivehttps://www.pharmaradar360.com/article/08cd524253791af4Pharma Surgeen2026-05-15T11:11:38.000ZThe brain’s “feel good” chemical may be secretly fueling tinnitushttps://www.pharmaradar360.com/article/5ceb2925b000336cPharma Surgeen2026-05-15T11:06:00.000ZEisai's slow push toward blockbuster Leqembi sales gains steam with $900M forecasthttps://www.pharmaradar360.com/article/9fb3d53d36ae6e87Pharma Surgeen2026-05-15T11:04:47.000ZKEMRI CONFERRED WITH A CHARTERhttps://www.pharmaradar360.com/article/cbdb2b4abcfa6e23Pharma Surgeen2026-05-15T11:00:01.000ZAndrea Pfeifer ends 23-year reign at AC Immune; Acadia's top R&D exec announces retirementhttps://www.pharmaradar360.com/article/80fbbf0e81b5e6daPharma Surgeen2026-05-15T11:00:00.000ZMaking eyes ‘photosynthetic’ could treat common vision problemhttps://www.pharmaradar360.com/article/ba176a9cba0434bbPharma Surgeen2026-05-15T10:58:05.000ZKielipankissa: Milla Uusitupahttps://www.pharmaradar360.com/article/41f6d460ed1d3c5ePharma Surgeen2026-05-15T10:47:00.000ZWashington AG alleges Providence failed to accommodate pregnant, nursing employeeshttps://www.pharmaradar360.com/article/70e3e8e6052f3b25Pharma Surgeen2026-05-15T10:46:51.000ZTempus broadens collaboration with BMS for clinical trialshttps://www.pharmaradar360.com/article/647f82b93b4825e4Pharma Surgeen2026-05-15T10:45:33.000Z#ASGCT26: A Zillow-like marketplace for abandoned gene therapies goes livehttps://www.pharmaradar360.com/article/b51c217c804426f3Pharma Surgeen2026-05-15T10:44:57.000ZArna Pharma and Slate Run complete JV for new US companyhttps://www.pharmaradar360.com/article/478820741b8a8bd0Pharma Surgeen2026-05-15T10:43:01.000ZPresident Ramaphosa honours SU academics for global contributions to healing and sciencehttps://www.pharmaradar360.com/article/6f4826da1eb648b0Pharma Surgeen2026-05-15T10:39:01.000ZOne in five people may carry this hidden cholesterol risk without knowing ithttps://www.pharmaradar360.com/article/e6e61cefaff883a5Pharma Surgeen2026-05-15T10:39:00.000ZSCOTUS temporarily restores telehealth access to abortion pill mifepristonehttps://www.pharmaradar360.com/article/30cc975837a6ca38Pharma Surgeen2026-05-15T10:39:00.000ZSCOTUS temporarily restores telehealth access to abortion pill mifepristonehttps://www.pharmaradar360.com/article/57d46e8a773bcee2Pharma Surgeen2026-05-15T10:34:00.000ZNovartis, amid reorg, cuts ‘select number’ of biomedical research roleshttps://www.pharmaradar360.com/article/f71d1f76db23bce7Pharma Surgeen2026-05-15T10:32:07.000ZBiopharma industry endorses Pazdur for FDA commissioner rolehttps://www.pharmaradar360.com/article/b86371e812d87150Pharma Surgeen2026-05-15T10:32:07.000ZBiopharma industry endorses Pazdur for FDA commissioner rolehttps://www.pharmaradar360.com/article/1680b0a5c5836382Pharma Surgeen2026-05-15T10:23:34.000ZBiogen forges on with Alzheimer’s therapy development despite Phase II misshttps://www.pharmaradar360.com/article/645a788df5c6fee8Pharma Surgeen2026-05-15T10:04:00.000ZInscrivez-vous au diplôme universitaire sur la recherche en soinshttps://www.pharmaradar360.com/article/57c0b0293ea100ddPharma Surgeen2026-05-15T10:00:45.000ZChinese-European mission to reveal shape of Earth’s magnetic shieldhttps://www.pharmaradar360.com/article/38317374b8e38f24Pharma Surgeen2026-05-15T10:00:17.000ZDigital Health’s monthly roundup of contracts and go liveshttps://www.pharmaradar360.com/article/e797e37b5c19e3f1Pharma Surgeen2026-05-15T10:00:00.000ZWomen’s Health Investment: Rhetoric vs. Realityhttps://www.pharmaradar360.com/article/1da6721ccea0417bPharma Surgeen2026-05-15T09:36:45.000ZHI-TAC: Karina Yaniv Appointed as New Scientific Directorhttps://www.pharmaradar360.com/article/123a6a9ac07d10d3Pharma Surgeen2026-05-15T09:22:11.000ZOutstanding nursing and midwifery staff celebratedhttps://www.pharmaradar360.com/article/5134cf80bedc135ePharma Surgeen2026-05-15T09:19:33.000ZThree PsA trials to watch in 2026https://www.pharmaradar360.com/article/0e95b528aa5f8571Pharma Surgeen2026-05-15T09:13:00.000ZHealth execs persevere in new policy landscapehttps://www.pharmaradar360.com/article/d976e305286eb8aaPharma Surgeen2026-05-15T09:02:54.000ZNHSGGC Statement – Red Wing Medical Practicehttps://www.pharmaradar360.com/article/6501dc7483256e53Pharma Surgeen2026-05-15T09:01:07.000ZUniversity of Oxford secures two International Cardiovascular Research Partnership Awardshttps://www.pharmaradar360.com/article/d33f3e8d7996e745Pharma Surgeen2026-05-15T09:00:09.000ZDNA‑Guided CRISPR Suggests a New Direction for RNA Editinghttps://www.pharmaradar360.com/article/bfe909f8d69db17dPharma Surgeen2026-05-15T08:45:18.000ZMassive Bio and Just Worldwide to expand cancer trial accesshttps://www.pharmaradar360.com/article/4d97cce944075cacPharma Surgeen2026-05-15T08:42:45.000ZKyowa Kirin secures FDA approval for Crysvita dosing updatehttps://www.pharmaradar360.com/article/e64a0c1b456aba2dPharma Surgeen2026-05-15T08:41:11.000ZUniversität Heidelberg Successful with Application for Collaborative Research Centrehttps://www.pharmaradar360.com/article/975b7aac9237cda3Pharma Surgeen2026-05-15T08:36:00.000ZAs biologics dominate biopharma pipelines, manufacturing hurdles trip up new launches: reporthttps://www.pharmaradar360.com/article/83cd153da6f8425fPharma Surgeen2026-05-15T08:30:00.000ZECO 2026: SURMOUNT-MAINTAIN proves tirzepatide sustains weight loss long termhttps://www.pharmaradar360.com/article/6b8499f41a027910Pharma Surgeen2026-05-15T08:17:46.000ZAncient cyanobacteria repurposed plasmid DNA, perhaps opening the door to multicellularityhttps://www.pharmaradar360.com/article/b2d3850b163222a5Pharma Surgeen2026-05-15T08:16:32.000ZCough & coldhttps://www.pharmaradar360.com/article/a8497e466877a7c9Pharma Surgeen2026-05-15T08:16:32.000ZPain managementhttps://www.pharmaradar360.com/article/4b4cd55fa1dd6689Pharma Surgeen2026-05-15T08:16:32.000ZNeurologyhttps://www.pharmaradar360.com/article/c0aff89e19d3cc93Pharma Surgeen2026-05-15T08:16:32.000ZCardiometabolichttps://www.pharmaradar360.com/article/47d337344087a4b0Pharma Surgeen2026-05-15T08:16:32.000ZIntim healthhttps://www.pharmaradar360.com/article/1caa88924c198621Pharma Surgeen2026-05-15T08:16:32.000ZGastroenterologyhttps://www.pharmaradar360.com/article/8fd9d23cc9e52abdPharma Surgeen2026-05-15T08:16:32.000ZSkin carehttps://www.pharmaradar360.com/article/53725b9002e42bccPharma Surgeen2026-05-15T08:16:32.000ZAntibiotics and antisepticshttps://www.pharmaradar360.com/article/d690ddf58d90c0d1Pharma Surgeen2026-05-15T08:16:32.000ZDrugs for Allergyhttps://www.pharmaradar360.com/article/066270a6295f5fadPharma Surgeen2026-05-15T08:16:32.000ZПрепарати від застуди та температуриhttps://www.pharmaradar360.com/article/f69bf9fb8c4ddf62Pharma Surgeen2026-05-15T08:16:32.000ZПрепарати від болю та запаленняhttps://www.pharmaradar360.com/article/0947fef84bc72938Pharma Surgeen2026-05-15T08:16:32.000ZНеврологічні препаратиhttps://www.pharmaradar360.com/article/aaa1bfa1c28e4363Pharma Surgeen2026-05-15T08:16:32.000ZКардіометаболічні препаратиhttps://www.pharmaradar360.com/article/dd4d70aaafbb7a6dPharma Surgeen2026-05-15T08:16:32.000ZПрепарати для інтимного здоров'яhttps://www.pharmaradar360.com/article/18af2a5c870c72f3Pharma Surgeen2026-05-15T08:16:32.000ZПрепарати для застосування у хірургіїhttps://www.pharmaradar360.com/article/ae82bbdf59d1be37Pharma Surgeen2026-05-15T08:16:32.000ZГастроентерологічні препаратиhttps://www.pharmaradar360.com/article/02066fd3fd616cdcPharma Surgeen2026-05-15T08:16:32.000ZДерматологічні препаратиhttps://www.pharmaradar360.com/article/0a091f728bc89826Pharma Surgeen2026-05-15T08:16:32.000ZАнтибактеріальні препарати та антисептикиhttps://www.pharmaradar360.com/article/51ea0cec05c70620Pharma Surgeen2026-05-15T08:16:32.000ZПрепарати при алергіїhttps://www.pharmaradar360.com/article/f5ed25629a28b133Pharma Surgeen2026-05-15T08:16:32.000ZПрепаратиhttps://www.pharmaradar360.com/article/e2a29d0aae4df370Pharma Surgeen2026-05-15T08:13:07.000ZCHE Ranking 2026: The University of Freiburg receives top ratingshttps://www.pharmaradar360.com/article/9901772df474da6dPharma Surgeen2026-05-15T08:13:00.000ZHeidelberger Sonderforschungsbereich „Molekulare Schaltkreise von Herzerkrankungen“ verlängerthttps://www.pharmaradar360.com/article/54fcb31cf3af8e5fPharma Surgeen2026-05-15T08:00:56.000ZNew wound research to tackle pain and cost of chronic woundshttps://www.pharmaradar360.com/article/7580f5505994c5c2Pharma Surgeen2026-05-15T08:00:00.000ZFreeze variability, not progress: strengthen your cell therapy supply chain from the starthttps://www.pharmaradar360.com/article/35e8a4a10e56e72aPharma Surgeen2026-05-15T07:51:00.000ZNeuroVision acquires fellow dx player Durin Life Scienceshttps://www.pharmaradar360.com/article/cc3900b201e24e09Pharma Surgeen2026-05-15T07:30:09.000ZUpdate for Jitendra Narayanhttps://www.pharmaradar360.com/article/1383c7b7a666d019Pharma Surgeen2026-05-15T07:30:00.000ZThe Clínic-IDIBAPS participates in the second EASL-Lancet Commission report calling for urgent action against liver diseases in Europehttps://www.pharmaradar360.com/article/eee948bf62d61991Pharma Surgeen2026-05-15T07:21:52.000ZSupreme Court preserves mail access for abortion pillhttps://www.pharmaradar360.com/article/4791fd606d6f12eaPharma Surgeen2026-05-15T07:15:07.000ZMed nål och tråd skapar Eva-Britt Hägg individuellt stöd till patienterhttps://www.pharmaradar360.com/article/003aaa891001b496Pharma Surgeen2026-05-15T07:03:00.000ZIm Portrait: Dr. Christina Mertenshttps://www.pharmaradar360.com/article/00d699d34ace992aPharma Surgeen2026-05-15T07:00:00.000ZUNMC, UNK celebrate opening of rural health education complexhttps://www.pharmaradar360.com/article/baa2d14f65059ffaPharma Surgeen2026-05-15T07:00:00.000ZRight medicine, right person: Jacintha Sivarajah on science with purposehttps://www.pharmaradar360.com/article/a1ae22af4d676949Pharma Surgeen2026-05-15T06:58:00.000ZPre-Dental Day a big success for UNMC student organizershttps://www.pharmaradar360.com/article/bad9baae2c13ebf7Pharma Surgeen2026-05-15T06:56:00.000ZApplications open for Interprofessional Academy of Educatorshttps://www.pharmaradar360.com/article/1d4b70dae0c2562dPharma Surgeen2026-05-15T06:52:00.000ZUNMC for the record, May 15, 2026https://www.pharmaradar360.com/article/37ce8493b4383751Pharma Surgeen2026-05-15T06:49:12.000ZAttenzione alle telefonate sospettehttps://www.pharmaradar360.com/article/d22fac740d71a281Pharma Surgeen2026-05-15T06:48:18.000ZGuy’s and St Thomas’ strengthens partnership with London South Bank University to support NHS workforcehttps://www.pharmaradar360.com/article/108e61e3c0c4e555Pharma Surgeen2026-05-15T06:30:09.000ZJames Murray appointed health secretaryhttps://www.pharmaradar360.com/article/219c0d94c77030a4Pharma Surgeen2026-05-15T06:04:24.000ZEn Lo Contador se iniciaron jornadas de diálogo en los campus en torno al Plan Estratégico UChttps://www.pharmaradar360.com/article/12fd7bfc2b41f898Pharma Surgeen2026-05-15T06:02:43.000ZDavid Schönach will defend his PhD thesishttps://www.pharmaradar360.com/article/c3cc04a96e501837Pharma Surgeen2026-05-15T05:42:44.000ZAmerican College of Radiology urges FDA to address breast biopsy needle shortageshttps://www.pharmaradar360.com/article/c7a403169d63b770Pharma Surgeen2026-05-15T05:39:41.000ZUnitedHealthcare seeks nearly 8% premium hike in 1 state, blaming rising radiology costshttps://www.pharmaradar360.com/article/4b4fba8322cd7ae2Pharma Surgeen2026-05-15T05:36:43.000Z2026年度 東北大学ジャパンバイオデザインフェローシッププログラム開講式を執り行いましたhttps://www.pharmaradar360.com/article/c4c9cf3e6a96a7afPharma Surgeen2026-05-15T05:30:00.000ZCDC plan to retire lab monkeys to Texas sanctuary draws irehttps://www.pharmaradar360.com/article/fba189a72dc8d238Pharma Surgeen2026-05-15T05:27:18.000ZRadiologist must pay $14,000 fine, undergo training after allegedly overlooking abnormalities on brain scanhttps://www.pharmaradar360.com/article/56cf48ddcc0b4115Pharma Surgeen2026-05-15T05:06:21.000ZOne Day at a Time: FDA’s New AI-Informed Inspection Pilot and What It Means for Industryhttps://www.pharmaradar360.com/article/5c3bb4d32bf6a39fPharma Surgeen2026-05-15T04:50:11.000ZA grad student’s wild idea sparks a major aging breakthroughhttps://www.pharmaradar360.com/article/5cf02d03bbe82010Pharma Surgeen2026-05-15T04:15:26.000ZA 47-year study reveals when strength and fitness start to fadehttps://www.pharmaradar360.com/article/fdf2b43304c40185Pharma Surgeen2026-05-15T03:46:00.000ZAlumis pulls back from would-be rival to Amgen’s Tepezza after assessing prospectshttps://www.pharmaradar360.com/article/7c45c96ecf7d7a9dPharma Surgeen2026-05-15T03:00:00.000Z[SHINSA]English Translation of Review Report: Setaneohttps://www.pharmaradar360.com/article/d3f7eea33ed562dcPharma Surgeen2026-05-15T02:58:00.000ZBridgeBio Pharma teams with awareness groups to spotlight ATTR-CM’s hidden impact on womenhttps://www.pharmaradar360.com/article/5013b9e7e4936272Pharma Surgeen2026-05-15T02:30:00.000ZNotice Regarding Continuation of the Performance-linked Stock Compensation Scheme and Performance-linked Stock Delivery Scheme for the Domestic and Global Astellas Group Executiveshttps://www.pharmaradar360.com/article/5e192b756f5bffa2Pharma Surgeen2026-05-15T02:30:00.000ZNotice Regarding Continuation of the Performance-linked Stock Compensation Schemehttps://www.pharmaradar360.com/article/37738bc25342c6f1Pharma Surgeen2026-05-15T01:52:00.000ZAardvark to dig into phase 3 data early after FDA imposes holdhttps://www.pharmaradar360.com/article/f0aeeb6d963c6203Pharma Surgeen2026-05-15T01:33:08.000ZThe key ingredients of a successful radiologist-wellness initiativehttps://www.pharmaradar360.com/article/131eb6d204046f1cPharma Surgeen2026-05-15T01:32:29.000ZIniciativa “Viaje del estudiante” acompañará a alumnos en hitos clave de su vida universitariahttps://www.pharmaradar360.com/article/4a5e3a5826e951e3Pharma Surgeen2026-05-15T00:50:57.000ZColon cancer is rising in young adults and doctors don’t fully know whyhttps://www.pharmaradar360.com/article/cc508c65304c272fPharma Surgeen2026-05-15T00:00:00.000ZCombined ctDNA and serum PSA for dynamic monitoring of metastatic prostate cancer starting first-line treatment: a prospective national cohort studyhttps://www.pharmaradar360.com/article/a49c2a87282adaa9Pharma Surgeen2026-05-15T00:00:00.000ZCD300ld on pathologically activated neutrophils promotes tumor immune suppression by binding phosphatidylserine on CD8 + T cellshttps://www.pharmaradar360.com/article/3e7c1946899de5b3Pharma Surgeen2026-05-15T00:00:00.000ZMulticentric data challenge for artificial intelligence-based classification of leukocytes: results from the CytologIA consortiumhttps://www.pharmaradar360.com/article/a0ed084c5bee7e81Pharma Surgeen2026-05-15T00:00:00.000ZToward scalable early cancer detection: evaluating EHR-based predictive models against traditional screening criteriahttps://www.pharmaradar360.com/article/5687d0d351605c04Pharma Surgeen2026-05-15T00:00:00.000ZAutism subtypes identified using cross-species functional connectivity analyseshttps://www.pharmaradar360.com/article/112418dfee5e72a1Pharma Surgeen2026-05-15T00:00:00.000ZExcitatory synapses onto axonic spines jump-start action potentials and route information flowhttps://www.pharmaradar360.com/article/60f5ddc8b070e13bPharma Surgeen2026-05-15T00:00:00.000ZParsing autism spectrum heterogeneity through fMRIhttps://www.pharmaradar360.com/article/893bffcaa36350c9Pharma Surgeen2026-05-15T00:00:00.000ZWhat Galen’s dissections reveal about tacit learning in modern medical educationhttps://www.pharmaradar360.com/article/4ba617e385cc7884Pharma Surgeen2026-05-15T00:00:00.000ZPopulation-scale genomic medicine with the Hong Kong Genome Projecthttps://www.pharmaradar360.com/article/88d19748d4ba5af2Pharma Surgeen2026-05-15T00:00:00.000ZFavipiravir for Lassa fever: an open-label, randomized controlled phase 2 trialhttps://www.pharmaradar360.com/article/5f5c5385db614845Pharma Surgeen2026-05-15T00:00:00.000ZGuide DNA — not RNA — expands the CRISPR toolkithttps://www.pharmaradar360.com/article/9d15c47e60608a43Pharma Surgeen2026-05-15T00:00:00.000ZWidespread DNA off-targeting confounds RNA chromatin occupancy studieshttps://www.pharmaradar360.com/article/109daebb160fa385Pharma Surgeen2026-05-15T00:00:00.000ZDNA-guided CRISPR–Cas12 for cellular RNA targetinghttps://www.pharmaradar360.com/article/61eed676600209d8Pharma Surgeen2026-05-15T00:00:00.000ZExploring biomarkers for treatment response in psoriatic arthritis: a focus on multi-omics technologieshttps://www.pharmaradar360.com/article/6390992353536550Pharma Surgeen2026-05-15T00:00:00.000ZUS biology lab locked down for more than a week amid smuggling inquiryhttps://www.pharmaradar360.com/article/5bb969e8afb493c0Pharma Surgeen2026-05-15T00:00:00.000ZBriefing Chat: Hantavirus — what this outbreak reveals about the diseasehttps://www.pharmaradar360.com/article/29b62d4b75e13a4cPharma Surgeen2026-05-15T00:00:00.000ZMouse eyes photosynthesize after plant-to-animal transplanthttps://www.pharmaradar360.com/article/8fc78ff02b7a13fcPharma Surgeen2026-05-15T00:00:00.000ZExclusive: NIH ousts infectious-disease leaders as COVID scientists face US chargeshttps://www.pharmaradar360.com/article/006116c742604a76Pharma Surgeen2026-05-15T00:00:00.000ZGenetic survey exposes flaws in widely used mouse modelshttps://www.pharmaradar360.com/article/0872fcf7cb03dcf7Pharma Surgeen2026-05-15T00:00:00.000ZEven mild blows to the head disrupt the microbiomehttps://www.pharmaradar360.com/article/4191fc7fdcc72df3Pharma Surgeen2026-05-15T00:00:00.000ZBespoke DNA vaccine offers hope for treatment of notorious brain cancerhttps://www.pharmaradar360.com/article/a38395e648b15e56Pharma Surgeen2026-05-15T00:00:00.000ZRunning a farm, pursuing a research career: what’s the difference?https://www.pharmaradar360.com/article/1d75c70065f40187Pharma Surgeen2026-05-15T00:00:00.000ZARS Pharmaceuticals Reports First Quarter 2026 Financial Results and Corporate Updatehttps://www.pharmaradar360.com/article/effc6d749a3e9b3fPharma Surgeen2026-05-15T00:00:00.000ZSmoking on Decline as Vaping Use Rises, CDC Reportshttps://www.pharmaradar360.com/article/bcf083d16ef866c5Pharma Surgeen2026-05-15T00:00:00.000ZCleveland Clinic Donates $1.25M to Children’s Hunger Alliance to Expand Preschool Nutrition Programshttps://www.pharmaradar360.com/article/7035041f7189090fPharma Surgeen2026-05-15T00:00:00.000ZUnited Therapeutics Corporation Announces FDA Clearance to Proceed with UHeart Xenotransplantation Clinical Trialhttps://www.pharmaradar360.com/article/20a49c8dfa773f1fPharma Surgeen2026-05-14T23:52:00.000ZWhy Model Medicines needs to ‘discover new colors’ in its AI drug discovery questhttps://www.pharmaradar360.com/article/22c15b4e26ed00f9Pharma Surgeen2026-05-14T23:50:45.000ZCancer waiting times: Latest updates and analysishttps://www.pharmaradar360.com/article/af0acb28bb7ab581Pharma Surgeen2026-05-14T23:30:00.000ZChina’s National Medical Products Administration Accepts New Drug Application for IZERVAY™ (avacincaptad pegol) for the Treatment of Geographic Atrophy Secondary to Age-Related Macular Degenerationhttps://www.pharmaradar360.com/article/2b07d29b4f58289ePharma Surgeen2026-05-14T23:21:10.000ZBest of ASCO 2026 in Japan開催のご案内https://www.pharmaradar360.com/article/d64c3a788e92c473Pharma Surgeen2026-05-14T21:56:47.000ZNew radiopharmaceutical achieves remission in difficult-to-treat pancreatic cancerhttps://www.pharmaradar360.com/article/a9e837c11b943994Pharma Surgeen2026-05-14T21:40:00.000ZImplantable Living Materials Contain Infection-Sensing Bacteria That Release Therapeuticshttps://www.pharmaradar360.com/article/6ca8bd5388278a87Pharma Surgeen2026-05-14T21:09:58.000ZPollen Allergies Are Brutal This Year – A Doctor Explains Why, and How to Find Reliefhttps://www.pharmaradar360.com/article/2c14988ae8694ddePharma Surgeen2026-05-14T21:00:49.000Z19th Annual Meeting of the Korean Society of Medical Oncology（KSMO2026）開催のご案内https://www.pharmaradar360.com/article/887acce9020da7d3Pharma Surgeen2026-05-14T21:00:03.000ZAnswers are in our DNA™https://www.pharmaradar360.com/article/1c3221788566127dPharma Surgeen2026-05-14T20:42:37.000ZCEDETi UC y Fundación Rassmuss desarrollan innovador test para abordar brechas de lecturahttps://www.pharmaradar360.com/article/5c274fdfaa7af741Pharma Surgeen2026-05-14T20:40:59.000ZSponsor’s Guide to IRB Approval (Part IV): Preparing IRB Documents That Prevent Delayshttps://www.pharmaradar360.com/article/2ba8d6d358781344Pharma Surgeen2026-05-14T20:34:00.000ZIDEXX Laboratories to Present at Stifel Conference and Announces 2026 Investor Dayhttps://www.pharmaradar360.com/article/f019f1286b1fd341Pharma Surgeen2026-05-14T20:20:01.000ZQ&A with Advarra’s Associate Director of Client Success Evan Sanderhttps://www.pharmaradar360.com/article/2e002588f86991e2Pharma Surgeen2026-05-14T20:15:33.000ZMedicaid Changes in House and Senate Reconciliation Bills Would Increase Costs for 1.3 Million Low-Income Medicare Beneficiarieshttps://www.pharmaradar360.com/article/04baebe9cc278c87Pharma Surgeen2026-05-14T20:06:41.000ZZymeworks Announces Share Repurchase Program of up to $125 Million of its Common Stockhttps://www.pharmaradar360.com/article/829a2b2d19e7bd2dPharma Surgeen2026-05-14T19:54:00.000ZOverview of President Trump’s Executive Actions Impacting LGBTQ+ Healthhttps://www.pharmaradar360.com/article/d559b1efb86a3f26Pharma Surgeen2026-05-14T19:06:03.000ZBeyond the Border: A Global Learning Experiencehttps://www.pharmaradar360.com/article/5af918e9e3e1a98cPharma Surgeen2026-05-14T18:50:34.000Z#ASGCT26: Encoded's gene therapy reduced seizures in Dravet syndromehttps://www.pharmaradar360.com/article/d6e0c4bd1c58f67aPharma Surgeen2026-05-14T18:50:13.000ZPharmaceutical Executive Daily: FDA Approves Beqalzi and Inqovihttps://www.pharmaradar360.com/article/70f2c64ad3f658cePharma Surgeen2026-05-14T18:45:37.000ZMolecular Anchors Help Tumor Therapies Stay Longer on Cancer Cellshttps://www.pharmaradar360.com/article/5f9a8e2893a3d9b3Pharma Surgeen2026-05-14T18:30:00.000ZTransforming Clinical Trial Design and Avoiding AI Wrappers: Q&A with Angela Schwabhttps://www.pharmaradar360.com/article/e87206f0468f9c04Pharma Surgeen2026-05-14T18:24:17.000Z#ASGCT26 dispatch: In vivo CAR-T is everywherehttps://www.pharmaradar360.com/article/f6a4ca47a8cc641fPharma Surgeen2026-05-14T18:21:25.000ZDiving safety this summerhttps://www.pharmaradar360.com/article/c6741008ebaebcb7Pharma Surgeen2026-05-14T18:20:56.000ZMarcha federal por la Universidad Públicahttps://www.pharmaradar360.com/article/efdde648713e8c87Pharma Surgeen2026-05-14T18:20:22.000ZMarcha Universitaria: facilidades académicas y administrativas en la UNLPhttps://www.pharmaradar360.com/article/18906c3c91c7338aPharma Surgeen2026-05-14T18:11:50.000ZEdward Fon appointed Director of The Neuro at McGill University and the MUHC-Santé Québec, and Chief of the Neuroscience Mission at MUHC-Santé Québechttps://www.pharmaradar360.com/article/7349a01fcb47eb3aPharma Surgeen2026-05-14T18:06:14.000ZLa Catedra UNESCO de la UNLP presentó el seminario internacional “Economía, Derechos Humanos y Orden internacional en Peligro: Desafíos y Oportunidades entre Italia y Argentina”https://www.pharmaradar360.com/article/81052fb94f3e3051Pharma Surgeen2026-05-14T18:00:00.000ZLocal businesswoman and mom raises awareness and funds to end women’s No. 1 health threathttps://www.pharmaradar360.com/article/6dfe1fe7b5fe2c61Pharma Surgeen2026-05-14T17:53:21.000ZThe ‘velocity of obesity’ aims to show which nations are slowing an epidemichttps://www.pharmaradar360.com/article/2466cc57c5016193Pharma Surgeen2026-05-14T17:49:34.000ZHey Minnesotans, want a wellness boost? Seek out a Sound Garden.https://www.pharmaradar360.com/article/69ffce3756b12549Pharma Surgeen2026-05-14T17:42:15.000ZThe (Literal) Pulsing Heart of Medtronic’s Relationship with the University of Minnesotahttps://www.pharmaradar360.com/article/f9176a0aac1ad256Pharma Surgeen2026-05-14T17:00:00.000ZEpic grows EHR footprint among small health systems even as overall market sales decline in 2025https://www.pharmaradar360.com/article/bf7d86e0942815a7Pharma Surgeen2026-05-14T16:59:19.000ZAI is No Longer the Bottleneck: Why Clinical Development Must Shift from Innovation to Executionhttps://www.pharmaradar360.com/article/50f1db08205612b7Pharma Surgeen2026-05-14T16:55:27.000ZIt’s A Fact: Sharing Clinical Trial Results With Participants Builds Trusthttps://www.pharmaradar360.com/article/9b90965593fc384ePharma Surgeen2026-05-14T16:55:13.000ZWhy 75 Top Pharma Execs Are Ditching Fragmented Marketing Stacks